ArticleThe American journal of case reports2022

Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report.

Masahiko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.